Axim Biotechnologies Inc (AXIM)

[TexasMarvL]

Potential silver lining exists for "ImmunoPass as RUO" (Research Use Only).


"ImmunoPass as RUO" sales will most likely be "business to business" sales (and interaction) with a large pharmaceutical company.

In my opinion, that "business to business" interaction with a large pharmaceutical company could open up future doors for AXIM.

My guess is that prior to Covid19, AXIM originally wanted to build their company and then become an attractive target for buyout. "ImmunoPass as RUO" might just open up a door that will facilitate a future buyout.

First get the Dry Eye Disease segment up and running. Then hopefully become profitable with DED. Start funding the Cancer Diagnostics test development.

Storm clouds today, but maybe a silver lining.